{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T16:17:57Z","timestamp":1791821877335,"version":"4.3.4"},"reference-count":32,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2017,7,1]],"date-time":"2017-07-01T00:00:00Z","timestamp":1498867200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,7,1]],"date-time":"2017-07-01T00:00:00Z","timestamp":1498867200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Research in Social and Administrative Pharmacy"],"published-print":{"date-parts":[[2017,7]]},"DOI":"10.1016\/j.sapharm.2016.10.002","type":"journal-article","created":{"date-parts":[[2016,10,11]],"date-time":"2016-10-11T23:03:51Z","timestamp":1476227031000},"page":"857-863","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":32,"title":["Discharge medication complexity and 30-day heart failure readmissions"],"prefix":"10.1016","volume":"13","author":[{"given":"A. Carmine","family":"Colavecchia","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David R.","family":"Putney","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael L.","family":"Johnson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rajender R.","family":"Aparasu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.sapharm.2016.10.002_bib1","doi-asserted-by":"crossref","first-page":"1418","DOI":"10.1056\/NEJMsa0803563","article-title":"Rehospitalizations among patients in the Medicare fee-for-service program","volume":"360","author":"Jencks","year":"2009","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.sapharm.2016.10.002_bib2","unstructured":"Centers for Medicare & Medicaid Services. Readmissions Reduction Program, February 2016. Available from http:\/\/cms.gov\/Medicare\/Medicare-Fee-for-Service-Payment\/AcuteInpatientPPS\/Readmissions-Reduction-Program.html. Accessed February 24, 2016."},{"key":"10.1016\/j.sapharm.2016.10.002_bib3","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1001\/jamainternmed.2013.3023","article-title":"Potentially avoidable 30-day hospital readmissions in medical patients","volume":"173","author":"Donze","year":"2013","journal-title":"JAMA Intern Med"},{"key":"10.1016\/j.sapharm.2016.10.002_bib4","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1016\/j.amjcard.2014.07.071","article-title":"Derivation and validation of a 30-day heart failure readmission model","volume":"114","author":"Fleming","year":"2014","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.sapharm.2016.10.002_bib5","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1097\/MLR.0b013e3181ef60d9","article-title":"An computerized model to identify heart failure patients at risk for 30-day readmission or death using electronic medical record data","volume":"48","author":"Amarasingham","year":"2010","journal-title":"Med Care"},{"key":"10.1016\/j.sapharm.2016.10.002_bib6","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/S0002-9343(99)00159-X","article-title":"Factors associated with unplanned hospital readmission among patients 65 years of age and older in a Medicare managed care plan","volume":"107","author":"Marcantonio","year":"1999","journal-title":"Am J Med"},{"key":"10.1016\/j.sapharm.2016.10.002_bib7","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1001\/archinte.168.13.1371","article-title":"Statistical models and patient predictors of readmission for heart failure: a systematic review","volume":"168","author":"Ross","year":"2008","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.sapharm.2016.10.002_bib8","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1161\/CIRCOUTCOMES.110.954693","article-title":"Incremental value of clinical data beyond claims data in predicting 30-day outcomes after heart failure hospitalization","volume":"4","author":"Hammill","year":"2011","journal-title":"Circ Cardiovasc Qual Outcomes"},{"key":"10.1016\/j.sapharm.2016.10.002_bib9","doi-asserted-by":"crossref","first-page":"1560","DOI":"10.1016\/S0735-1097(99)00059-5","article-title":"Prediction of hospital readmission for heart failure: development of a simple risk score based on administrative data","volume":"33","author":"Philbin","year":"1999","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.sapharm.2016.10.002_bib10","doi-asserted-by":"crossref","first-page":"1907","DOI":"10.1016\/j.amjcard.2013.08.014","article-title":"Comparison of predictors of heart failure\u2014related hospitalization or death in patients with versus without preserved left ventricular ejection fraction","volume":"112","author":"Mangla","year":"2013","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.sapharm.2016.10.002_bib11","first-page":"e240","article-title":"ACCF\/AHA guideline for the management of heart failure: a report of the American college of cardiology foundation\/American heart association task force on practice guidelines","volume":"128","author":"Yancy","year":"2013","journal-title":"Circulation"},{"key":"10.1016\/j.sapharm.2016.10.002_bib12","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1177\/1060028013510898","article-title":"Medication regimen complexity and hospital readmission for an adverse drug event","volume":"48","author":"Willson","year":"2014","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.sapharm.2016.10.002_bib13","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1097\/PTS.0000000000000067","article-title":"Predicting potential postdischarge adverse drug events and 30-day unplanned hospital readmissions from medication regimen complexity","volume":"10","author":"Schoonover","year":"2014","journal-title":"J\u00a0Patient Saf"},{"key":"10.1016\/j.sapharm.2016.10.002_bib14","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1016\/S0140-6736(00)02212-1","article-title":"Long-term ACE-inhibitor therapy in patients with heart failure or left-ventricular dysfunction: a systematic overview of data from individual patients. ACE-Inhibitor Myocardial Infarction Collaborative Group","volume":"355","author":"Flather","year":"2000","journal-title":"Lancet"},{"key":"10.1016\/j.sapharm.2016.10.002_bib15","doi-asserted-by":"crossref","first-page":"550","DOI":"10.7326\/0003-4819-134-7-200104030-00008","article-title":"Beta-blockers in congestive heart failure. A Bayesian meta-analysis","volume":"134","author":"Brophy","year":"2001","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.sapharm.2016.10.002_bib16","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1056\/NEJM199702203360801","article-title":"The effect of digoxin on mortality and morbidity in patients with heart failure","volume":"336","author":"The Digitalis Investigation Group","year":"1997","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.sapharm.2016.10.002_bib17","article-title":"Diuretics for heart failure","volume":"4","author":"Faris","year":"2016","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.sapharm.2016.10.002_bib18","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1056\/NEJM199909023411001","article-title":"The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators","volume":"341","author":"Pitt","year":"1999","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.sapharm.2016.10.002_bib19","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/j.jacc.2005.04.038","article-title":"Eplerenone reduces mortality 30 days after randomization following acute myocardial infarction in patients with left ventricular systolic dysfunction and heart failure","volume":"46","author":"Pitt","year":"2005","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.sapharm.2016.10.002_bib20","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1345\/aph.1D479","article-title":"Development and validation of the medication regimen complexity index","volume":"38","author":"George","year":"2004","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.sapharm.2016.10.002_bib21","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1002\/phar.1452","article-title":"Validation of a patient-level medication regimen complexity index as a possible tool to identify patients for medication therapy management intervention","volume":"34","author":"Hirsch","year":"2014","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.sapharm.2016.10.002_bib22","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/j.clinthera.2013.02.019","article-title":"Patient-Level medication regimen complexity across populations with chronic disease","volume":"35","author":"Libby","year":"2013","journal-title":"Clin Ther"},{"key":"10.1016\/j.sapharm.2016.10.002_bib23","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1177\/2050312116632426","article-title":"Medication regimen complexity and readmissions after hospitalization for heart failure, acute myocardial infarction, pneumonia, and chronic obstructive pulmonary disease","volume":"4","author":"Abou-Karam","year":"2016","journal-title":"SAGE Open Med"},{"key":"10.1016\/j.sapharm.2016.10.002_bib24","first-page":"713","article-title":"Changes in medication regimen complexity and the risk for 90-day hospital readmission and\/or emergency department visits in U.S. Veterans with heart failure","volume":"12","author":"Yam","year":"2016","journal-title":"RSAP"},{"key":"10.1016\/j.sapharm.2016.10.002_bib25","series-title":"Regression Methods in Biostatistics: Linear, Logistic, Survival, and Repeated Measures Models","author":"Vittinghoff","year":"2012"},{"key":"10.1016\/j.sapharm.2016.10.002_bib26","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1093\/oxfordjournals.aje.a116813","article-title":"Simulation study of confounder-selection strategies","volume":"138","author":"Maldonado","year":"1993","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.sapharm.2016.10.002_bib27","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1056\/NEJM199209033271003","article-title":"Effect of enalapril on mortality and the development of heart failure in asymptomatic patients with reduced left ventricular ejection fractions","volume":"327","author":"The SOLVD Investigators","year":"1992","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.sapharm.2016.10.002_bib28","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1056\/NEJM199108013250501","article-title":"Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure","volume":"325","author":"The SOLVD Investigators","year":"1991","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.sapharm.2016.10.002_bib29","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1016\/j.ejheart.2008.09.009","volume":"10","author":"Rossi","year":"2008","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.sapharm.2016.10.002_bib30","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/j.jacc.2012.09.038","article-title":"Rehospitalization for heart failure: problems and perspectives","volume":"61","author":"Gheorghiade","year":"2013","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.sapharm.2016.10.002_bib31","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1002\/clc.4960260906","article-title":"Predictors of cause-specific hospital readmission in patients with heart failure","volume":"26","author":"Babayan","year":"2003","journal-title":"Clin Cardiol"},{"key":"10.1016\/j.sapharm.2016.10.002_bib32","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1002\/clc.20453","article-title":"Current trends in heart failure readmission rates: analysis of medicare data","volume":"32","author":"Aranda","year":"2009","journal-title":"Clin Cardiol"}],"container-title":["Research in Social and Administrative Pharmacy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1551741116304788?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1551741116304788?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T09:11:48Z","timestamp":1761556308000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1551741116304788"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,7]]},"references-count":32,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2017,7]]}},"alternative-id":["S1551741116304788"],"URL":"https:\/\/doi.org\/10.1016\/j.sapharm.2016.10.002","relation":{},"ISSN":["1551-7411"],"issn-type":[{"value":"1551-7411","type":"print"}],"subject":[],"published":{"date-parts":[[2017,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Discharge medication complexity and 30-day heart failure readmissions","name":"articletitle","label":"Article Title"},{"value":"Research in Social and Administrative Pharmacy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.sapharm.2016.10.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}